Home / Recalls / Teva Pharmaceuticals USA, Inc / D-0561-2024

D-0561-2024 Class II Ongoing

Recalled by Teva Pharmaceuticals USA, Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
June 26, 2024
Initiation Date
June 4, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
34,448 bottles

Product Description

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34

Reason for Recall

Subpotent Drug

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024

Other recalls by Teva Pharmaceuticals USA, Inc

  • D-0355-2026 Class II — Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: (January 29, 2026)
  • D-0356-2026 Class II — Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bott (January 29, 2026)
  • D-0354-2026 Class II — Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: (January 29, 2026)
  • D-0357-2026 Class II — Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx O (January 29, 2026)
  • D-0198-2026 Class III — Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose p (November 7, 2025)
  • D-0151-2026 Class II — Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg pe (October 13, 2025)
  • D-0104-2026 Class II — Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMA (October 7, 2025)
  • D-0106-2026 Class II — Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMA (October 7, 2025)
  • D-0105-2026 Class II — Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMA (October 7, 2025)
  • D-0473-2025 Class II — Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Cr (May 23, 2025)